Edgewell stock hits 52-week low at $24.35 amid market challenges

Edgewell Personal Care (EPC) hit a 52-week low after reporting Q2 2025 earnings that missed EPS and revenue forecasts, with adjusted EPS at $0.87 versus $0.90 expected and revenue at $580.7 million versus $591.01 million expected. The company's stock has declined 25.29% year-to-date amid increased competition and shifting consumer preferences, prompting Canaccord Genuity to lower its price target to $35 while maintaining a Buy rating; management has revised annual guidance downward, projecting adjusted EPS between $2.85 and $3.05, anticipating a sales rebound in the second half of 2025 despite tariff pressures and higher advertising costs.

Analysis

Edgewell Personal Care Company (NYSE:EPC) has reached a 52-week low of $24.35, reflecting a significant 25.29% year-to-date decline amidst a challenging market characterized by heightened competition and evolving consumer preferences. Despite these headwinds, the company exhibits solid fundamentals, including a current ratio of 1.89 and a modest P/E ratio of 14.2, with InvestingPro analysis suggesting the stock is undervalued. The recent downturn was exacerbated by second-quarter 2025 results that missed analyst expectations, with adjusted earnings per share (EPS) at $0.87 against a $0.90 forecast, and revenue of $580.7 million versus an expected $591.01 million. This performance included a 4% decline in North American sales, partially offset by a 3% growth in international sales. Consequently, Edgewell's management has revised its full-year adjusted EPS guidance downward to between $2.85 and $3.05. However, the company anticipates a sales rebound in the latter half of 2025, driven by potential improvements in sun care sales and the resolution of supply chain issues, a view shared by Canaccord Genuity, which, despite lowering its price target to $35 from $40, maintained a Buy rating. Edgewell did achieve a 100 basis point improvement in its adjusted gross margin and reported an adjusted EBITDA of $99.3 million, though it continues to face pressures from tariffs, estimated at a $3-4 million impact for the year, and increased advertising expenditures. The company remains focused on strategic investments and operational enhancements to navigate these challenges.

Key Decisions for Investors

• Investors should consider the current depressed valuation and InvestingPro's undervaluation assessment as a potential entry point, balanced against the risks of ongoing market headwinds and recent earnings misses.
• Closely monitor Edgewell's ability to achieve its H2 2025 sales rebound, particularly improvements in sun care, supply chain normalization, and effective management of tariff impacts and advertising costs, as these are critical for a potential stock recovery.
• Given the mixed signals of a lowered price target yet maintained 'Buy' rating from Canaccord Genuity and management's revised downward guidance, it may be prudent to await further confirmation of operational improvements and market stabilization before making significant investment decisions.